communiqués les plus récents de la salle de presse
Nasdaq Copenhagen A/S
A number of name changes of funds under Investeringsforeningen Jyske Invest
will take effect as per 24 January 2017.
For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33
93 33 66
Based on preliminary reporting, TDC upgrades its guidance on 2016 equity free
cash flow (EFCF) from EFCF > DKK 1,700m to EFCF ~ DKK 2,100m. The better result
is primarily driven by different timing of changes in net working capital.
At the Q3 2016 results announcement, TDC’s EFCF guidance was improved from EFCF
~ DKK 1,700m to EFCF > DKK 1,700m.
As earlier announced, TDC’s financial statement 2016 will be disclosed on 3
Oasmia Pharmaceutical AB
Uppsala, January 23, 2017 – Oasmia Pharmaceutical AB (NASDAQ: OASM), a
developer of a new generation of drugs within human and veterinary oncology,
today announced that it plans to move all of the Company’s veterinary assets
including Paccal Vet and Doxophos Vet, to the United States for further
development and commercialization efforts.
The development of veterinary oncology technologies has been of great
significance to Oasmia’s product development over the years and the Company has